The underlying mechanisms for the 'anti-HBc alone' serological profile

Archives of Virology

Volumn 155, Issue 2, 2010, Pages 149-158

  Ponde R A A ^a,b,c,d   Cardoso, D D P ^a   Ferro, M O ^e,f  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Central Goiana de Sorologia Imuno hematologia e Biologia Molecular   (Brazil)

^c Hospital Materno Infantil   (Brazil)

^d Laboratório Saúde ^*  (Brazil)

^e Laboratório Saúde   (Brazil)

^f Laboratório Jardim América   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

BLOOD; FEMALE; HEPATITIS B; HUMAN; IMMUNOLOGY; MALE; PREGNANCY; REVIEW;

FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; MALE; PREGNANCY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 76349092060     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0559-6     Document Type: Review

References (89)

1. Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234: 1398-1401.
2. Milich DR, Salberg M, Maruyama T (1995) The humoral immune response in acute and chronic hepatitis B virus infection. Springer Semin Immunopathol 17: 140-166.
3. Jung M-C, Pape GR (2002) Immunology of hepatitis B infection. Lancet 2(1): 43-50.
4. Laperche S, Guitton C, Smilovici W, Courouce AM (2001) Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen. Vox Sang 80: 90-94.
5. Busch MP (2004) Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Tranfus Clin Biol 11(1): 26-32.
6. Alhababi F, Sallam T, Tong C (2003) The significance of 'anti-HBc alone' in the clinical virology laboratory. J Clin Virol 27: 162-169.
7. Chan H (2002) Changing scene in hepatitis B serology interpretation. Hosp Med 63(1): 16-19.
8. Greub G, Frei PC (2001) Presence of low levels on anti-HBs antibody in so-called 'anti-HBc alone' subjects. Liver 21: 380-383.
9. Grob JP, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I (2000) Serological pattern 'anti-HBc Alone': report on a workshop. J Med Virol 62: 450-455.
10. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H (2001) Hepatitis B virus markers in Anti-HBc only positive individuals. J Med Virol 64: 312-319.
11. Westh H, Hoffmann S, Christian E, Worm AM (1996) Hepatitis B core antibody screening in a high prevalence group: comparison of the three enzyme immunoassays using receiver operating characteristic analysis. J Virol Med 56(1): 13-18.
12. Weber B, Michl U, Muhlbacher A, Paggi G, Bossi V (1998) Evaluation of the new automated enzymun-test anti-HBc plus for the detection of hepatitis B virus core antibody. Intervirology 41(1): 17-23.
13. Weare JA, Robertson EF, Madsen G, Hu R, Decker RH (1991) Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen. J Clin Microbiol 29(3): 600-604.
14. Ural O, Findik D (2001) The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 43(3): 187-190.
15. Lai C-L, Johnson Y, Yeoh E-K, Chang W-K, Lin H-J (1992) Significance of Isolated Anti-HBc Seropositivity by ELISA: implications and the role of radioimmunoassay. J Med Virol 36: 180-183.
16. Rodriguez JC, García DG, Teruel AB, Lorenz NF, Espeja AG (2005) Significado de la reactividad aislada anti-HBc como único marcador de infeccíon de la hepatitis B. Enferm Infecc Microbiol Clin 23(1): 80-85.
17. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T (2000) Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31(2): 488-495.
18. Noborg U, Anki G, Horal P, Magnus L (2000) Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 32: 249-252.
19. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Bréchot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 1(34): 194-203.
20. Zoulim F (2005) New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 42: 302-308.
21. Loriot M-A, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S (1997) Persistence of hepatitis B Virus DNA in serum and Liver from patients with chronic hepatitis B after Loss of HBsAg. J Hepatol 27: 251-258.
22. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, Chevalier P, Mandrand B, Trépo C (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 34: 447-454.
23. Zuckerman AJ, Zuckerman JN (2000) Current topics in hepatitis B. J Infect 41: 130-136.
24. Weber B (2004) The diagnostic and clinical impact of the genetic variability of the s gene of hepatitis B virus. J Lab Med 28(1): 56-69.
25. Tonekaboni SS, Waters J, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Howard C, Karayiannis P (2000) Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60: 113-121.
26. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillop G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325-329.
27. Karthiguesu V, Allison L, Fortuin M, Mendy M, Whittle H, Howard C (1994) A novel hepatitis B virus in the sera of immunized children. J Gen Virol 75: 443-448.
28. Jongerius J, Cuypers H, van Oostendorp W, Lelie PN, van der Poel CL, Leeuwen EF (1998) New hepatitis B virus mutant form in a blood donor that in undetectable in several hepatitis B surface antigen screening assays. Transfusion 38: 56-59.
29. Grethe S, Monazahian M, Bohme I, Thomsen R (1998) Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 9(72): 7692-7696.
30. Weinberger KM, Bauer T, Bohm S, Jilg W (2000) High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81: 1165-1174.
31. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R (1995) Fulminant reactivation of hepatitis B virus due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 1406-1407.
32. Stuyver L, Locarnini S, Lok A, Richman D, Carman W, Dienstag J (2001) Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33: 751-757.
33. Torresi J (2002) The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 25(2): 97-106.
34. Torresi J, Erneste-Silveira L, Civitico G, Walters T, Lewin S, Fyfe J, Locarnini S, Manns M, Trautwein C, Bock T (2002) Restoration of replication phenotype of lamivudine-resistant Hepatitis B mutants by compensatory changes in the fingers subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 299(1): 88-99.
35. Wakil SM, Kazim SN, Khan LA (2002) Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus. J Med Virol 68: 311-318.
36. Pichoud C, Seigneres B, Wang Z, Trepo C, Zoulim F (1999) Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology 29: 230-237.
37. Xiong X, Yang H, Westland CE, Zou R, Gibbs CS (2000) In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance. Hepatology 31: 219-224.
38. Krastev AZ (2006) The "return" of hepatitis B. W J Gastroenterol 12(44): 7081-7086.
39. Pastor R, Habersetzer F, Fafi-Kremer S, Doffoel M, Baumert Tf, Gut J-P, Stoll-Keller F, Schvoerer E (2009) Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naïve patients. W J Gastroenterol 15(6): 753-755.
40. Nagasaki F, Niitsuma H, Ueno Y, Imoue J, Kogure T, Fukushima K, Shimisegawa T (2007) The high incidence of the emergence of entecavir-resistant mutant among patients infected with Lamivudine-resistant hepatitis B virus. Tohoku J Exp Med 213: 181-186.
41. Angus P, Vaughan R, Yiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Ayres A, Bartholomeusz A, Locarnini S (2003) Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutations in the HBV polymerase. Gastroenterology 125: 292-297.
42. Sheldon J, Camino N, Rodes B (2005) Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenefovir. Antivir Ther 10: 727-734.
43. Yang H, Westland CE, Delaney W (2002) Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks. Hepatotlogy 36: 464-473.
44. Baumert TF, Blum HE (2005) Hepatitis B virus mutations: molecular biology and clinical relevance. Vir Rev 6: 177-192.
45. Baumert TF, Thimme R, von Weizsacker F (2007) Pathogenesis of hepatitis B virus infection. W J Gastroenterol 13(1): 82-90.
46. Kazim SN, Sarin SK, Sharme BC, Khan LA, Hasnain SE (2006) Characterization of naturally occurring and lamivudine-induced surface gene mutations of hepatitis B virus in patients with chronic hepatitis B in India. Intervirol 49: 152-160.
47. Sheldon J, Ròdes B, Zoulim F, Bartholomeusz A, Soriano V (2006) Mutations affecting the replication capacity of the hepatitis B virus. J Virol Hep 13: 427-434.
48. Bock C, Tillmann H, Manns M, Trautwein C (1999) The pre-S region determines the intracellular localization and appearance of hepatitis B virus. Hepatology 30(2): 517-525.
49. Melegari M, Pier PS, Wands JR (1997) The small envelope protein is required for secretions of a naturally occurring Hepatitis B virus mutant with Pre-S1 deleted. J Virol 7(71): 5449-5454.
50. Bock C, Tillman H, Maschek H, Manns M, Trautwein C (1997) A pre-S mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113: 1976-1982.
51. Lee S-Y, Choi MS, Lee D, Lee H, Koh KC, Paik SW, Yoo BC (2005) Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. J Korean Med Sci 20: 433-437.
52. Sengupta S, Rehman S, Durgapal H, Acharya S, Panda S (2007) Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol 79: 220-228.
53. Blackberg J, Kidd-Ljunggren K (2000) Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 33: 992-997.
54. Squadrito G, Orlando M, Pollicino T, Raffa G, Restuccia T, Cacciola I, Di Marco V, Picciotto A, Colucci G, Craxi A, Raimondo G (2002) Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 97(6): 1518-1523.
55. Otedo AE, McLigeyo SO, Okoth FA, Kayima JK (2003) Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J 93(5): 380-384.
56. De-Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J, van Thiel DH (2000) The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 95(12): 3529-3536.
57. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S, Watanabe M, Kinoshita Y (1999) Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 58(3): 201-207.
58. Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46: 160-170.
59. Inigo R, Mariscal L, Bartolomé J, Castillo I, Navacerrada C, Movilla N, Pardo M, Carrero V (2003) Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection. J Med Virol 70: 571-580.
60. Weber B, Melchior W, Gehrke R, Doerr WH, Berger A, Rabenau H (2001) Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 64: 312-319.
61. Schuttler C, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S (2002) Suppression of hepatitis B virus enhancer 1 e 2 by hepatitis C virus core protein. J Hepatol 37(6): 855-862.
62. Lusida MI, Sakugawa H, Motroko N-F, Muluanto S, Handajani R, Boediwarsono, Setiawan PB, Nidom CA, Ohgimoto S and Hotta H (2003) Genotype and Subtype Analyses of Hepatitis B Vírus (HBV) and Possible Co-Infection of HBV and Hepatitis C Virus (HCV) or Hepatitis D Vírus (HDV) in Blood Donors, Patients with Chronic Liver Disease and Patients on Hemodialysis is Surabaya, Indonesia. Microbiol Immunol 47(12): 969-975.
63. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR (1993) The serology of chronic hepatitis B infection revisited. J Clin Invest 91: 2586-2595.
64. Joller-Jemelka HI, Wicki AN, Grob P (1994) Detection of HBs antigen in 'anti-HBc alone' positive sera. J Hepatol 21(2): 269-272.
65. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujioe H, Tsutsumi T, Kimura S, Koike K (1998) Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27(5): 1377-1382.
66. Greub G, Frei P (2001) Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects. Liver 21: 380-383.
67. Yamauchi K, Nakanishi T, Chiou S-S, Obata H (1998) Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers. Lancet 1: 324-326.
68. Bocher WO, Herzog-Hauff S, Schlaak J, Meyer zum Buschenfeld K, Lohr HF (1999) Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 29(1): 238-244.
69. Milich DR, Leroux-Roels GG (2003) Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2(5): 248-257.
70. Desombere I, Willems A, Gijbels Y, Leroux-Roels G (2006) Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen. J Virol 80(7): 3506-3514.
71. Wang R-X, Boland G, Hattum J, de Gast GC (2004) Long term persistence of T cell memory to HBsAg after hepatitis B vaccination. World J Gastroenterol 10(2): 260-263.
72. Bocher B, Herzog-Hauff S, Herr W, Heermann K, Gerken G, Meyer ZUMB, Lohr HF (1996) Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol 105(1): 52-58.
73. Bauer T, Jilg W (2006) Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 24(5): 572-577.
74. Greub G, Zysset F, Genton B, Spertini F, Frei PC (2001) Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response. Med Microbiol Immunol (Berl) 189(3): 165-168.
75. Heijtink RA, Schneeberger PM, Postma B, Crombach W (2002) Anti-HBs levels after hepatitis B immunization depend on test reagents: routinely determined 10 and 100 IU/L seroprotection levels unreliable. Vaccine 20(23/24): 2899-2905.
76. Hou J, Lui Z, Gu F (2005) Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2(1): 50-57.
77. Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet 2: 395-403.
78. Allain J-P (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86: 83-91.
79. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV (2001) Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-years prospective study in Northwestern Greece. Transfusion 41: 652-658.
80. Liu C-J, Chen D-S, Chen P-J (2006) Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection ant the role of NAT. J Clin Virol 36: S33-S44.
81. Wang JT, Wang TH, Lee C-Z, Chen P-J, Wang T-H, Chen D-S (2002) Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 42: 1592-1597.
82. Arraes LC, Ximenez R, Andrieu J-M, Lu-W, Barreto S, Pereira LM, Castelo A (2003) The biological meaning of anti-HBc positive in blood donors: Relation to HBV-DNA and to other serological markers. Rev Inst Med Trop S Paulo 45(3): 137-140.
83. García-Montalvo B, Farfán-Ale J, Acosta-Viana K, Puerto-Manzano F (2005) Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, México. Transfus Med 15(5): 371-378.
84. Ramia S, Ramlawi F, Kanaan M, Klayme S, Naman R (2005) Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiol Infect 133(4): 695-699.
85. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A (2006) Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 123(1): 37-42.
86. Banerjee A, Chandra P, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya S, Chakrabarty R (2007) Frequency and significance of hepatitis B virus surface gene variant circulating among 'anti-HBc only' individuals in Eastern India. J Clin Virol 40: 312-317.
87. Kleinman S, Kuhns M, Todd D, Glynn S, McManara A, DiMarco A, Busch M (2003) Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 43: 696-704.
88. Sciariada L, Grando D, Lochato A, Magni E (1991) Immune response to hepatitis B vaccine in persons with "anti-HBcAlone". In: Hollinger FB, Lemon SM, Margolis HS (eds) Proceedings of the 1990 international symposium on viral hepatitis and liver disease: viral hepatitis and liver disease. Willians & Wilkins, pp 782-784.
89. Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S (2000) Response to hepatitis B vaccine in HBsAg/Anti-HBs negative and anti-HBc positive subjects. Scan J Infect Dis 32: 315-316.